Leveraging Partnerships to Accelerate the Journey from an iPSC Line to a Patient Cure
- The challenges with sourcing fit for purpose iPSC lines from earliest steps and the substantial gains with accessing high-quality GMP-compliant lines
- How to fast-track drug development and secure value chain by onboarding gene-editing methodologies, differentiation and expansion protocols developed for scalability and GMP-compatibility
- The importance of teaming from early days with an expert manufacturing partner, who has a sharp understanding of the partner program, strategic plans, and environment